| Add to balance / Manage account | User: | Log out |
| Prospect News home > News index > List of issuers H > Headlines for Horizon Pharma USA, Inc. > News item |
Horizon Pharma USA to redeem 6 5/8% notes and 8¾% notes Aug. 9
By Angela McDaniels
Tacoma, Wash., July 16 – Horizon Pharma USA, Inc. will redeem its $225 million of 6 5/8% senior notes due 2023 and $300 million of 8¾% senior notes due 2024 on Aug. 9, according to an 8-K filing with the Securities and Exchange Commission.
The company also said it prepaid $100 million principal amount of senior secured term loans outstanding under its May 7, 2015 credit agreement.
The company is repaying the $625 million of debt with $65 million of cash on hand and the proceeds of $600 million of 5½% senior notes due 2027.
Horizon Pharma USA is a subsidiary of Dublin-based biopharmaceutical company Horizon Therapeutics plc.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.